Atlas Trials

Clinical Study on the Safety and Efficacy of CD19-BCMA CAR-T Cell Therapy for Connective Tissue Diseases

Clinical trial NCT07152223 · WITHDRAWN

Trial details

NCT number
NCT07152223
Sponsor
Guangzhou Bio-gene Technology Co., Ltd
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Connective Tissue Diseases
Start date
2025-08-07
Primary completion
2026-03-02
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.